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The Ethics of 
International Bureaucracies 
Abortion and the Human Reproduction Programme 
An interview with Australian Senator Brian Harradine 
Canberra, Australia, April, 1990 
The World Health Organization (WHO) is involved in many laudable 
activities, supported by thousands of loyal and active workers, both in the 
field and in educational, scientific, health, and medical establishments. 
To many of these dedicated workers, it will be a source of much 
disappointment and shame, therefore, to learn that WHO has become 
involved in activities in which its motto "healthfor all" is being interpreted 
in such a way as to discriminate against the health and well-being of 
particular unborn children. 
In this interview, Senator Harradine seeks to answer matters of serious 
concern which have arisen concerning the direction of the Human 
Reproduction Programme (HRP) of which WHO is co-sponsor and 
executing agency. 
The Human Reproduction Programme 
THE HUMAN REPRODUCTION PROGRAMME (HRP) was estab-
lished in 1971-72 by the World Health Organisation to "coordinate, promote, 
conduct and evaluate international research in human reproduction."1 Its full 
title is "The Special Programme of Research, Development and Research 
Training in Human Reproduction". 
The HRP was a programme of the World Health Organisation (WHO) until 
1988 when the World Bank, the United Nations Population Fund (UNFPA) 
and the United Nations Development Programme (UNDP) joined WHO as 
co-sponsors. WHO retains the predominant position of Executing Agency. 
The HRP has published annual reports, the last of which was the Annual 
Report 1985. The H RP now publishes reports every two years. The first of these 
- the Biennial Report 1986-1987 - was published in 1988. The Biennial 
Report 1988-1989 should be available mid-1990 . 
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Interview 
(Q) Senator, you have been publicly critical in recent years of the 
involvement of the Human Reproduction Programme (HRP) in devising 
new abortion technology. Can you explain your concerns? 
(A) I am concerned about the lack of proper ethical evaluation and 
public scrutiny of the HRP programme, and about the population control 
mentality which seems to be a prime motivation of many of those involved. 
I can elaborate on these issues later if you wish. 
Specifically, the solid backing the HRP has given , and continues to give, 
to the development, the testing and the trialing of new abortion technology 
is a most disturbing - and most destructive - aspect of the HRP. 
(Q) What new abortion technology are your referring to? 
(A) The abortion drug RU 486, and the abortion-producing anti-hCG 
vaccine. 
The HRP has had a long involvement in the development of new 
abortion drugs. Until 1985, the HRP had a special Task Force - the Task 
Force on Prostaglandins for Fertility Regulation - the aims of which, 
according to the HRP Annual Report 1985 were: 
I. The development of a non-surgical method for which the termination of 
early first trimester pregnancy which could , in suitable circumstances, be self-
administered or supervised on an outpatient basis; 
2. The development of a non-surgical , non-invasive method for the 
termination of second trimester pregnancy."2 
This anti-life research has been going on for nearly 20 years. It's because 
of the furore over R U 486 that ordinary people are beginning to realise 
that, in this area, WHO has a great deal to answer for. 
(Q) You mentioned RU 486. The HRP AnnuaiReportl985 said that an 
HRP Task Force - the newly-formed Task Force on Post-Ovulatory 
Methods - had "made research on these compounds its top priority."3 
The Report then says that the HRP wants to make RU 486 available as 
soon as possible so that "the public may benefit from this breakthrough in 
fertility regulation."4 Do you sense a delirious excitement within the HRP 
over this new abortion technology? 
(A) The HRP is not taking credit for originally developing the abortion 
drug RU 486. This is not the work of Dr. Baulieu of France, and the 
Roussel-UCLAF drug company. What the HRP is openly proud of is its 
work in making R U 486 more "effective", and specifically, in showing that 
R U 486 will be more effective in aborting the unborn if it is used in 
combination with a prostaglandin.s 
A number of scientists, the drug company with a vested interest, and 
population controllers have made statements tinged with delirium about 
R U 486. The HRP Task Force involved indicated in 1988 that their main 
emphasis will continue to be on clinical trials to establish what mix of 
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R U 486 and prostaglandin will most "effectively" destroy the unborn6, and 
on testing of the so-called "NIH antiprogestins", abortion drugs 
synthesised by a USA institute under contract from the National Institutes 
of Health. 6a 
Q. The WHO "Statement on RU 486" says that "although abortion is 
not acceptable as a family planning method (WHO emphasis) the 
Programme recognises that safe and effective medical methods of early 
termination of pregnancy have the potential for less adverse side effects 
(psychological, physical and medical) than surgical methods."7 Do you 
accept this argument? 
A. This is not a "value-free" argument. There is no mention of the 
unborn child. WHO is indicating that it is not concerned about the health 
of the tiny victim of abortion. 
WHO's assertion of "less adverse side effects" - the correct term is "ill 
effects" is curious. Apart from the doubtful character of such conjecture, 
under what article of its charter does WHO involve itself with developing 
and testing a drug which does not cure or manage a disease but, rather, 
results in death for the unborn and ill effects for the mother? 
Q. WHO justifies this by arguing that, after all, abortion is legal in many 
countries, and that the health and medical implications of unsafe abortion 
in less developed countries, are such that WHO, under its mandate, must 
intervene. Do you accept this? 
Abortion Lobby 
A. Let me use this analogy. WHO is actively involved in the current 
debate over the health implications of cigarette smoking. But is WHO 
encouraging the use of filters? Is it encouraging the use of cigarettes with 
lower nicotine or tar content? On the contrary, it is actively discouraging 
people from smoking. It is saying: smoking is bad, smoking is wrong. You 
must quiP 
Yet, when it comes to something which has as many ethical implications 
as abortion, what does WHO do? It adopts the position of the abortion 
lobby: abortion is here to stay, so we must make it "safer" and more 
"effective". 
Frankly, it is disturbing to find WHO putting forward the same 
arguments in defence of abortion as are being put forward by many 
anti-life activists in our current national abortion debates . 
Q. Do you think pro-abortion elements have conspired to shape the 
HRP agenda? 
A. I prefer not to refer to it as a conspiracy. However, I do believe that 
the HRP has provided a unique forum where pro-abortion interests and 
the technological imperative have coincided. 
For instance, priorities and policies within the HRP are effectively set 
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by a small group of scientists who form the Scientific and Technical 
Advisory Group (STAG). Yet, how many people know that Dr. E. 
Baulieu, the so-called "father of RU 486," was appointed to this group in 
1985? Furthermore, Baulieu co-edited a book in 1985 on R U 486 with the 
Rockefeller Foundation's Dr. Sheldon Segal who , it turns out , also 
because a member of STAG in 1985. 
(Q) Have WHO managers tried to limit the pro-abortion influence on 
the direction of the HRP? 
(A) With an organisation as large and as complex as WHO it is difficult 
to establish how decisions were made and priorities determined. The 
evidence now emerging, however, points to the strong support that WHO 
managers gave to these elements of the HRP programme. 
Just in the last year we have had two ex-WHO bureaucrats both putting 
their weight behind the abortion drug R U 486. 
First, there was Halfdan Mahler, Director of WHO until 1988, and now 
the head of the International Planned Parenthood Federation - an 
organisation which the United States no longer funds because it supports 
abortion. He was recently reported to have accused opponents of R U 486 
of adopting a "fanatic ideological posture".9 
Then we had the Director of the HRP until 1989, Jose Barzelatto, now a 
senior advisor to the Ford Foundation, who was recently quoted as saying 
that RU 486 "must be made availablefor humanitarian reasons", calling it 
a "glaring injustice that the most deprived women cannot share in the 
medical advances enjoyed by their sisters in France."lo 
(Q) Dr. Nafis Sadik - who is now head of one of the HRP co-sponsors, 
the United Nations Population Fund, UNFP A - told a fertility 
symposium in 1983 that: 
" ... I would say that a menses inducer which was self-administered could really 
change the course of family planning programmes ... a woman could then be 
free to take something, not after coitus or at other times , but only when she 
thought she was pregnant .. . If I had the choice and the authority, I would put 
the major research investment in this one area."" 
Do you think R U 486 has come as a "magic bullet" to the population 
control movement? 
(A) With this attitude, and coming from someone who now has much 
"authority" as head of UNFPA, abortion drugs like RU 486 and the 
anti-heG abortifacient vaccine will clearly slot easily into existing 
popUlation control delivery systems. The ultimate objective of the 
popUlation control movement is control over women's bodies , making 
them slaves to drugs and anti-life devices . Australia's current representa-
tive on STAG, Professor R. V. Short, said as far back as 1969 that "if we 
are to control human populations, one of the things we need to control is 
the human corpus luteum."12 That is what these new abortion drugs will 
do . . 
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(Q) When the HRP attempts to justify this work by claiming that more 
efficient abortion technology is needed for health reasons, are you saying 
that it is not telling the whole truth? 
(A) There are two ways of assessing this. The first is to look at what the 
HRP has said about the abortion drug R U 486, and the second is to look at 
how others view it. 
A study of HRP documents reveals that RU 486 is not just about 
making the killing of the unborn "safer" in developing countries. The 
agenda is much wider. For instance, the HRP Annual Report 1985 talks 
about it constituting "a more pragmatic approach by offering fertility 
regulation if and when needed."13 
In other words , the HRP itself sees RU 486 as a major new approach , 
not only to abortion, but to birth control. 
Outside the HRP, RU 486 is being hailed , not because it is an advance in 
so-called "reproductive health", but because, as a prominent birth control 
advocate , Carl Djerassi , said in July last year, it will be "the most 
significant research achievement of the 1990's in new practical fertility 
control."14 
(Q) The other weapon in what you have termed chemical warfare against 
the unborn is the anti-hCG vaccine. What stage is this vaccine at? 
(A) For a number of years, the HRP has been working on the 
development of a vaccine that would have the effect of making the 
mother's body reject the embryo that has implanted , or is in the process of 
implanting, in her womb. The human embryo produces a hormone called 
hCG, or human Chorionic Gonadotrophin. This hormone is essential for 
implantation and the maintenance of pregnancy. The effect of the vaccine 
would be to effectively neutralise this hormone, and the human embryo 
would die. 
Phase I trials have been conducted in Adelaide , Australia, by Professor 
Warren Jones, under the supervision of the drug company which owns the 
patent, Sandoz, and on behalf of the HRP. Work is also being done by a 
number of scientists in the US, and by organisations like the New York-
based Population Council. A marketable vaccine is still a few years down 
the track. I believe that the H RP is aiming for a vaccine that will be 
effective for two to five years. 
(Q) When you spoke at the "New Era for Life" conference in Manila in 
June 1988 you asked the question: "Has 'good medicine' and world health 
policy come to this: that for the first time in human history our newest 
members of the human race are to be regarded as a disease for which a 
vaccine must be found?" Is it fair to think of this particular vaccine in such 
terms?15 
(A) I actually borrowed the analogy from the HRP itself. In the Annual 
Report 1984, for example , the HRP argues that the widespread 
72 Linacre Quarterly 
"acceptance" of a birth control vaccine is assured because of the "success 
achieved by immunization programmes in controlling infectious 
diseases. "16 
The HRP continually refers to how this vaccine will "revolutionise" 
family planning in developing countries - it talks about how such a 
vaccine would be an "attractive addition to the present family planning 
armamentarium" - and will be readily "accepted" because people in these 
countries are already familiar with vaccination procedures.17 
This worries me greatly. Can you imagine what power over women such 
a vaccine is going to give the population controllers in places like China, 
Bangladesh, or Indonesia? As the depo-provera saga has shown, injectable 
population control drugs in an era of population control mania are 
inherently dangerous . 
The anti-hCG vaccine is bad news. If the HRP scientists and 
technologists get their way, the first casualty will be the unborn. The 
second casualty will be the truth . The anti-hCG vaccine is an abortion-
producing vaccine. It is not a contraceptive vaccine as some scientists have 
tried to label it. They are not telling the public the truth . Given the past 
record of population control programmes, it is highly unlikely that women 
in the developing countries will be told the truth as to how the vaccine 
works either. 
(Q) Earlier you agreed that some scientists and others appeared 
somewhat delirious at what they considered to be this new "pragmatic 
approach to feritIity regulation", ie RU 486. A recent issue of the journal 
Science, claimed that anti-fertiliy vaccines "would radically change our 
perception of human fertility if teenage males or females or both were 
vaccinated so that they would be infertile until a conscious step was taken 
to achieve fertility."1 8 
Does this conflict with the official HRP line that "abortion is not 
acceptable as a means of family planning"? 
(A) It certainly indicates that the H RP has a wider agenda than it 
normally admits. I believe the official line on abortion is designed to 
assuage pro-life concerns. But it is hollow rhetoric. On the one hand , the 
HRP says it does not accept abortion for fertility regulation purposes. Yet 
on the other hand, it is rushing to develop new abortion technology which, 
like the anti-hCG vaccine, will become part of the family planning 
"armamentarium", or which , like th R U 486 abortion drug, will be , to 
quote the HRP, a "more pragmatic approach by offering fertility 
regulation if and when needed", and "essential to remedy the consequences 
of contraceptive failure". 19 
The HRP can't have it both ways. It can't say, as it did in its Annual 
Report 1983, that its objective is "to develop for family planning 
programmes entirely new birth control modalities which they consider 
would considerably extend acceptance and use, eg ... abortifacient drugs , 
vaccines ... "20, and then turn around and say that "abortion is not 
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acceptable as a means of family planning." 
Norcan the HRP wash its hands of the uses to which others are claiming 
the new abortion technology will - and, they would urge, should - be 
put. The scientists clearly think these new abortifacients are the family 
planning techniques of the future. The HRP should stop trying to delude 
the public, and itself, into believing otherwise. 
(Q) Many people would be quite shocked to hear all this. How is it that 
an organisation are reputable as the World Health Organisation could 
become so deeply involved in research that, from a pro-life perspective, is 
of sudl great concern? 
(A) My belief is that the answer lies in two aspects of the Human 
Reproduction Programme: its ethos, and its ethics. 
The HRP was born at a time when the population "bomb" theory was 
fashionable, and mostly well-meaning governments the world over were 
looking for solutions as to how this "bomb" might be defused . 
(Q) Wasn't it the hysteria and doomsday pessimism that needed 
defusing? 
(A) That's true, but the mood at the time, influenced by such pessimists 
as Paul Ehrlich - who is currently going through a recycling phase 
-precluded rational and calm debate. In this climate, WHO launched the 
HRP and gave it a mandate to improve existing methods and develop new 
techniques that could be used primarily to stem population growth in the 
developing countries. 
(Q) The extent ofthe population control rhetoric in theB;enn;alReport 
1986-1987 is quite surprising. One of the senior HRP officials, Dr 
Mahmoud Fathalla, wrote in that report that "the unregulated quantity of 
human reproduction has thus become a major global concern with the 
balance between man and nature in serious jeopardy and the entire future 
of mankind at stake."21 Coming from a man who has just taken over as the 
new Director of the HRP, this attitude - this climbing aboard the 
eco-doom bandwagon - must be of some concern to you? 
(A) I believe that the Annual Report 1986-1987 indicated a marked 
deterioration of the HRP attitude to popUlation control. This overt linking 
of the HRP agenda with the doomsday scenario is cause for great concern. 
(Q) Why do you think the HRP has openly embraced this mentality? 
(A) I believe that this is due to a large extent to the recent co-sponsorship 
of the HRP by organisations such as the United Nations Population Fund 
(UNFPA), and the cosy relationship the HRP has with pressure groups 
like the International Planned Parenthood Federation and the Population 
Council. 
All of these groups have sought to re-justify their existence in terms that 
sound deceptively sweet to an environmentally-conscious world. 
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Other elements combine with this population control mentality to form 
the HRP ethos. I mentioned earlier the "technological imperative". The 
idea that what can be done should and shall be done is very strong within 
the HRP, influenced largely by the dominance of scientists and 
technologists in the Programme. They feel they are at the cutting edge, the 
technological coal-face in birth control research, and nothing will stop 
them, or, as Dr. Barzelatto, the former HRP Director, said recently of 
abortion drugs like RU 486, "they're too important to be stopped."22 
When you put these two elements together, what emerges is a mind-set 
that urges these HRP scientists on to develop ever more efficient 
technology - including abortion technology - which they then turn over 
to the population controllers. This is part of the HRP ethos. 
(Q) What about ethical considerations? 
(A) I first raised the issue of the ethical evaluations undertaken by the 
HRP in the Australian Parliament in October 1988. Let me read from the 
Hansard the question I asked: 
.. I ask whether prior to the decision by that Committee [of the H RP] to trial. 
test , and possibly use the abortifacient anti-hCG vaccine and the drug R U 486 for 
termination of pregnancy. was there any ethical evaluation at international level 
prior to the request made to the Department [DCSH , Australia] regarding their 
trial in Australia? If there was , who undertook such evaluationsT23 
The response I received from the Department of Community Services 
and Health was that it was "not aware of any ethical evaluation at the 
international level prior to the decision by WHO to trial and possibly use 
the abortifacient anti-hCG vaccine or the abortion drug RU 486."24 
(Q) But, you did receive a less straightforward reponse from the HRP? 
(A) An official at the Australian Embassy in London did consult Dr 
Barzelatto , the Director of the H R P at that time. I have here a copy of the 
response provided by Dr Barzaletto. He claims that the abortifacient 
anti-hCG vaccine and the abortion drug RU 486 "underwent ethical 
evaluation at the international level during the exhaustive process of 
sequential review . .. " . But when you scrape the rhetoric away it is scientists 
reviewing scientists. 
As I indicated earlier, the real power within the H R P lies with the small 
Scientific and Technical Advisory Group, members of which include such 
people as Dr Baulieu. In practice, the HRP takes the view that the research 
is too important to stop. If one country won't allow trials to take place, it 
will find another country that will. 
(Q) The resurgence in pro-life concerns, particularly in the United 
States, has led to the HRP coming under fire from many directions. Is the 
HRP likely to reassess its priorities? 
(A) I think we need to examine the defence mechanisms that large and 
centralised international organisations , like WHO, display when 
August , 1990 75 
contronted by criticism. 
We have already seen WHO shift responsibility for the HRP to three 
other international organisations, while retaining a very large finger in the 
pie. This is going to make it much harder to scrutinise HRP activities. 
These organisations will all rally to defend the H RP when anyone 
challenges this so-called "emerging international consensus" on issues 
concerning human reproduction. 
Also, we are witnessing a major effort by the H RP to export its ethos to 
developing countries. According to the Annual Report 1986-1987. of a 
total budget for the 1986/ 87 biennium of US$22. 7 million, approximately 
US$13 million went to "strengthening" institutions in developing countries 
and for training scientists from such countries. This is a very long and 
lavish gravy train . Having scientists in developing countries cloned in the 
image and values of some anti-life scientists in the West will undoubtedly 
pose grave problems for humankind . 
(Q) WHO traditionally has a good image. Is this a stumbling block? 
(A) The first hurdle that a person or organisation concerned about the 
nature of HRP research must clear is the good name and reputation that 
WHO has within the community. I believe that WHO is conscious that this 
image enables it to pursue research which, if carried out by other, more 
tangible or controversial organisations, could attract criticism. 
(Q) In an article written in April 1989, Dr Barzaletto noted that "the 
work of WHO in the field of human reproduction covers an extremely 
sensitive and controversial field ... ", and he mentions specifically, 
"research directed to the medical termination of pregnancy."25 
(A) The point about that is not that WHO or the HRP is in any way 
apologetic about this involvement in abortion research. The former 
Director-General of WHO, Halfdan Mahler, now with IPPF, said way 
back in 1983 that WHO's perceived neutrality made it "a most appropriate 
instrument to deal with an area as sensitive as that of family planning 
research ."26 In other words, it believed it could avoid the abortion debate, 
and the political scrutiny and community concern that such anti-life 
research should involve. 
(Q) In a 1987 article, it was stated that "fewer and fewer pharmaceutical 
companies are undertaking research on new methods offertility regulation 
... hence ... a greater burden is placed on the public sector agencies - such 
as WHO's Special Programme of Research in Human Reproduction ... "27 
Are you concerned at this trend? 
(A) It is true that the public sector is moving in where some drug 
companies - particularly in the United States - are moving out. 
It is also true that the strong stand the United States has taken against 
abortion has influenced the decision of a number of international 
organisations to take the lead in this area . The Australian Government's 
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advisor on HRP matters actually wrote in November 1984 that "the recent 
strong stand of the USA at the International Conference on Population 
against abortion and funding for organisations which encourage or 
promote abortion in their programs makes it unlikely that the USA will 
become a donor to the HRP."28 In 1985 she added that "because of the 
USA attitude on abortion, WHO is the only agency which can support 
research in this area."28 
This indicates that the strong US position against abortion has had a 
wide-ranging and positive impact. Nevertheless, the implications of this 
trend towards greater public sector involvement are such that pressure 
must be brought to bear on these international organisations to abandon 
their support for abortion , and abortion drugs . 
(Q) No doubt there are ways in which ordinary citizens can influence the 
debate. Do you think that the recent "greening" of the World Bank 
indicates that big bureaucracies can and do respond to the concerns of 
ordinary people? 
(A) The "greening" of the World Bank should serve as a reminder that 
bureaucratic or utilitarian scientist-controlled organisations can and do 
change, but are unlikely to change on their own initiative. 
First, we need to tackle the technological imperative mentality. The 
HRP must not be allowed to hide behind the "we are only here to serve the 
international community by developing more efficient abortion tech-
nology" smokescreen. All actions have consequences, and ethics must not 
be sacrificed in the rush to develop more potent chemical weapons against 
the unborn . 
Second, we must point out the dangerous linking of the HRP to 
population control mania. Cases like the inherently coercive population 
control programme in China, which the HRP is actively supporting, 
illustrates the point that new technology produced by the HRP cannot be 
divorced from the use to which it will be put. This point was not lost on the 
judges at Nuremburg. 
Third, the HRP must be challenged on the assertion that it is developing 
more advanced abortion technology because "after all , abortion is legal in 
many countries." Once these abortion drugs are ready for use , we can be 
sure that the World Bank, IPPF, WHO, and UNFPA will press for their 
use everywhere. Not to mention the impact of international drug 
companies with vested interests, and those groups with other agendas 
which say that this abortion technology, once developed, is the "moral 
property" of women everywhere. 
(Q) What about the question of funding the HRP? 
(A) Most governments provide money to WHO. WHO, in turn , gave the 
HRP US$816,OOO in 1987. Many governments fund the World Bank. In 
1987, the World Bank gave the HRP US$I million. UNFPAgave it US$3 
million, the UK gave US$3 .83 million, and the combined Sweden/ 
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Denmark/ Norway grant was US$7. i million. 
(Q) How actively has Australia supported the HRP? 
(A) Australia first began contributing to the HRP in 1980, and has 
provided about US$1.2 million since, the last grant being A$250,000 in 
1989/ 90. This money comes from the foreign aid budget of the Australian 
International Development Assistance Bureau (AIDAB). 
AIDAB has not widely broadcast its involvement in the HRP. It is 
apparent that population control remains an important element of our 
involvement. In a briefing note for the Australian representative at the 
annual meeting of the H RP governing body in 1982, the representative was 
told not to support moves that could end up "putting the whole goal of 
population control injeopardy."29 An AIDAB booklet published in 1988 
referred to the Australian grant to the HRP as supporting "research on 
population control".30 Only recently, and under pressure, has AIDAB 
started to tone down this line. 
(Q) The Australian Minister for Foreign Affairs and Trade, Senator 
Gareth Evans, said in March 1989 that "the humanitarian and maternal 
health implications of developing safer, non-invasive technology for 
pregnancy termination are much clearer than the ethical and religious 
aspects."31 Does this satisfy your concerns? 
(A) It actually confirms the fears I have expressed all along. Technology 
should not be put before ethics. The development of new methods of 
killing the unborn can hardly be described as a "humanitarian" way of 
spending our foreign aid dollars . 
The Minister's comments show an abysmal ignorance of the widespread 
human rights violations perpetrated by popUlation controllers who, in the 
1990's, expect to receive the HRP abortion technologies into their 
"armamentarium". 
(Q) You campaigned in 1988 to have trials of the abortion drug RU 486 
stopped in Australia, and Roussel ended up withdrawing their clinical trial 
application. Despite the influence ofthe abortion lobby on the direction of 
the HRP, are you confident that those who support pro-life values can 
influence the future direction of the programme? 
(A) In that 1982 briefing note , the representative of the Australian 
Government on the HRP was informed that "HRP attracts public 
criticism in Australia" but that "such criticism evaporates when the facts 
are stated and understood (eg on abortion . . . )".32 
That was in 1982. When we look at the facts in 1990 and see that the right 
to life of the unborn child is being treated with greater contempt, and see 
that women in the developing countries are still being treated as pawns in 
the deadly game of popUlation control, the criticisms are not going to 
"evaporate". 
(Q) What does the future hold for the HRP? 
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(A) I will continue to vigorously pursue these issues of major public 
policy, and I am confident that concerned people, both in the pro-life 
movement and in the wider community, will use whatever opportunities 
they have to project these issues and demand action. 
I believe that the influence of the population control lobby on the HRP 
will become more evident. However, as one of those genuinely concerned 
about the environment, I refuse to accept the view being promoted by 
population control bureaucrats whose fatal diagnosis is that people 
growth in developing countries is the cause of global environmental 
problems and population control the solution. This diagnosis is deceptive, 
simplistic, and directs attention away from the real problems. 
It is our disposable, throw-away society which is polluting its own 
environment. This same mentality is now poisoning society's respect for 
human life - the very respect which is fundamental to all human rights . 
This week I am attending an Inter-Parliamentary Conference on the 
Global Environment convened by the US Senate. As in the past, a number 
of international organisations will be lobbying for greater resources to be 
spent on population control and human reproduction research. In a 
subsequent interview, I will deal with issues raised by the resurgence of this 
population control mentality. 
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